David Carcedo (David Carcedo Rodriguez)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Sentinel Lymph Node

Ejection Fraction

Small Cell Lung Cancer

Liver Metastases

Top Venues

Cancer medicine

BMC pulmonary medicine

JCO precision oncology

Journal of clinical pathology

This page only lists publications with an associated author ORCID identifier.

Publications

Sandra Zazo, Sandra Pérez-Buira, Nerea Carvajal, Jenifer Plaza-Sánchez, Rebeca Manso, Nuria Pérez-González, Carolina Dominguez, Iván Prieto-Potin, Jaime Rubio, Manuel Dómine, Virginia Lozano, Patricia Mohedano, David Carcedo, Rafael Carias, Federico Rojo
Actionable mutational profiling in solid tumors using hybrid-capture-based next-generation sequencing in a real-world setting in Spain. Cancer medicine 13 (3) (2024)
Sandra Zazo, Sandra Pérez-Buira, Nerea Carvajal, Jenifer Plaza-Sánchez, Rebeca Manso, Nuria Pérez-González, Carolina Dominguez, Iván Prieto-Potin, Jaime Rubio, Manuel Dómine, Virginia Lozano, Patricia Mohedano, David Carcedo, Rafael Carias, Federico Rojo
Actionable mutational profiling in solid tumors using hybrid-capture-based next-generation sequencing in a real-world setting in Spain. Cancer medicine 13 (3) (2024)
Sandra Zazo, Sandra Pérez-Buira, Nerea Carvajal, Jenifer Plaza-Sánchez, Rebeca Manso, Nuria Pérez-González, Carolina Dominguez, Iván Prieto-Potin, Jaime Rubio, Manuel Dómine, Virginia Lozano, Patricia Mohedano, David Carcedo, Rafael Carias, Federico Rojo
Actionable mutational profiling in solid tumors using hybrid-capture-based next-generation sequencing in a real-world setting in Spain. Cancer medicine 13 (3) (2024)
Sandra Zazo, Sandra Pérez-Buira, Nerea Carvajal, Jenifer Plaza-Sánchez, Rebeca Manso, Nuria Pérez-González, Carolina Dominguez, Iván Prieto-Potin, Jaime Rubio, Manuel Dómine, Virginia Lozano, Patricia Mohedano, David Carcedo, Rafael Carias, Federico Rojo
Actionable mutational profiling in solid tumors using hybrid-capture-based next-generation sequencing in a real-world setting in Spain. Cancer medicine 13 (3) (2024)
Sandra Zazo, Sandra Pérez-Buira, Nerea Carvajal, Jenifer Plaza-Sánchez, Rebeca Manso, Nuria Pérez-González, Carolina Dominguez, Iván Prieto-Potin, Jaime Rubio, Manuel Dómine, Virginia Lozano, Patricia Mohedano, David Carcedo, Rafael Carias, Federico Rojo
Actionable mutational profiling in solid tumors using hybrid-capture-based next-generation sequencing in a real-world setting in Spain. Cancer medicine (2024)
Javier De Castro, Amelia Insa, Roberto Collado-Borrell, Vicente Escudero-Vilaplana, Alex Martínez, Elena Fernandez, Ivana Sullivan, Natalia Arrabal, David Carcedo, Alba Manzaneque
Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in Spain. BMC pulmonary medicine 23 (1) (2023)
Edurne Arriola, Reyes Bernabé, Rosario García Campelo, Michele Biscuola, Ana Belén Enguita, Fernando López-Ríos, Rafael Martínez, Laura Mezquita, Sarai Palanca Suela, María Jesús Pareja, Jon Zugazagoitia, Natalia Arrabal, J Francisco García, David Carcedo, Enrique de Álava
Cost-Effectiveness of Next-Generation Sequencing Versus Single-Gene Testing for the Molecular Diagnosis of Patients With Metastatic Non-Small-Cell Lung Cancer From the Perspective of Spanish Reference Centers. JCO precision oncology 7 (2023)
Vicente Escudero-Vilaplana, Roberto Collado-Borrell, Javier De Castro, Amelia Insa, Alex Martínez, Elena Fernández, Ivana Sullivan, Andrés Flores, Natalia Arrabal, David Carcedo, Alba Manzaneque
Cost-effectiveness of adjuvant atezolizumab versus best supportive care in the treatment of patients with resectable early-stage non-small cell lung cancer and overexpression of PD-L1. Journal of medical economics (2023)
Javier De Castro, Amelia Insa, Roberto Collado-Borrell, Vicente Escudero-Vilaplana, Alex Martínez, Elena Fernandez, Ivana Sullivan, Natalia Arrabal, David Carcedo, Alba Manzaneque
Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in Spain. BMC pulmonary medicine 23 (1) (2023)
Javier De Castro, Amelia Insa, Roberto Collado-Borrell, Vicente Escudero-Vilaplana, Alex Martínez, Elena Fernandez, Ivana Sullivan, Natalia Arrabal, David Carcedo, Alba Manzaneque
Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in Spain. BMC pulmonary medicine 23 (1) (2023)
Edurne Arriola, Reyes Bernabé, Rosario García Campelo, Michele Biscuola, Ana Belén Enguita, Fernando López-Ríos, Rafael Martínez, Laura Mezquita, Sarai Palanca Suela, María Jesús Pareja, Jon Zugazagoitia, Natalia Arrabal, J Francisco García, David Carcedo, Enrique de Álava
Cost-Effectiveness of Next-Generation Sequencing Versus Single-Gene Testing for the Molecular Diagnosis of Patients With Metastatic Non-Small-Cell Lung Cancer From the Perspective of Spanish Reference Centers. JCO precision oncology 7 (2023)
Enrique de Álava, María Jesús Pareja, David Carcedo, Natalia Arrabal, José-Francisco García, Reyes Bernabé
Cost-effectiveness analysis of molecular diagnosis by next-generation sequencing versus sequential single testing in metastatic non-small cell lung cancer patients from a south Spanish hospital perspective. Expert review of pharmacoeconomics & outcomes research 22 (6) (2022)
Clara Salas, Javier Martín-López, Antonio Martínez-Pozo, Teresa Hernández-Iglesias, David Carcedo, Lucia Ruiz de Alda, J Francisco García, Federico Rojo
Real-world biomarker testing rate and positivity rate in NSCLC in Spain: Prospective Central Lung Cancer Biomarker Testing Registry (LungPath) from the Spanish Society of Pathology (SEAP). Journal of clinical pathology (2021)
Javier Martín-López, Federico Rojo, Antonio Martínez-Pozo, Teresa Hernández-Iglesias, David Carcedo, Lucía Ruiz de Alda, J Francisco García, Clara Salas
Biomarker testing strategies in non-small cell lung cancer in the real-world setting: analysis of methods in the Prospective Central Lung Cancer Biomarker Registry (LungPath) from the Spanish Society of Pathology (SEAP). Journal of clinical pathology (2021)
Ernest Nadal, Dolores Bautista, Luis Cabezón-Gutiérrez, Ana Laura Ortega, Héctor-Enrique Torres-Rivas, David Carcedo, Lucía Ruiz de Alda, J Francisco Garcia, Paula Vieitez, Federico Rojo
Clinical and economic impact of current ALK rearrangement testing in Spain compared with a hypothetical no-testing scenario. BMC cancer 21 (1) (2021)
David Carcedo, Teresa Artola Urain, Anabelle Chinea Rodriguez, Estefanía García Torres, Marta González Vicent, Gonzalo Gutiérrez García, Alexandra Regueiro García, Marcos Calvo Hidalgo, Alba Villacampa
Cost-effectiveness analysis of defibrotide in the treatment of patients with severe veno-occlusive disease/sinusoidal obstructive syndrome with multiorgan dysfunction following hematopoietic cell transplantation in Spain. Journal of medical economics 24 (1) (2021)